 | • レポートコード：MRC23Q37138 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の薬剤溶出バルーン（DEB）市場について調査・分析し、世界の薬剤溶出バルーン（DEB）市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（末梢DEB、冠動脈DEB）、用途別セグメント分析（カテーテル検査室、病院、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、B. Braun、Medtronic、Boston Scientific、BD、Yinyi、Philips、Eurocor、Aachen Resonance、Biotronicなどが含まれています。 世界の薬剤溶出バルーン（DEB）市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、薬剤溶出バルーン（DEB）市場規模を推定する際に考慮しました。本レポートは、薬剤溶出バルーン（DEB）の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、薬剤溶出バルーン（DEB）に関するビジネス上の意思決定に役立てることを目的としています。 ・薬剤溶出バルーン（DEB）市場の概要 - 製品の定義 - 薬剤溶出バルーン（DEB）のタイプ別セグメント - 世界の薬剤溶出バルーン（DEB）市場規模：タイプ別分析（末梢DEB、冠動脈DEB） - 薬剤溶出バルーン（DEB）の用途別セグメント - 世界の薬剤溶出バルーン（DEB）市場規模：用途別分析（カテーテル検査室、病院、その他） - 世界の薬剤溶出バルーン（DEB）市場規模予測（2018年-2029年） - 薬剤溶出バルーン（DEB）の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 薬剤溶出バルーン（DEB）市場の競争状況およびトレンド ・薬剤溶出バルーン（DEB）の地域別市場規模 - 北米の薬剤溶出バルーン（DEB）市場規模（2018年-2029年） - アメリカの薬剤溶出バルーン（DEB）市場規模（2018年-2029年） - ヨーロッパの薬剤溶出バルーン（DEB）市場規模（2018年-2029年） - アジア太平洋の薬剤溶出バルーン（DEB）市場規模（2018年-2029年） - 中国の薬剤溶出バルーン（DEB）市場規模（2018年-2029年） - 日本の薬剤溶出バルーン（DEB）市場規模（2018年-2029年） - 韓国の薬剤溶出バルーン（DEB）市場規模（2018年-2029年） - インドの薬剤溶出バルーン（DEB）市場規模（2018年-2029年） - オーストラリアの薬剤溶出バルーン（DEB）市場規模（2018年-2029年） - 中南米の薬剤溶出バルーン（DEB）市場規模（2018年-2029年） - 中東・アフリカの薬剤溶出バルーン（DEB）市場規模（2018年-2029年） ・タイプ別セグメント：末梢DEB、冠動脈DEB - 世界の薬剤溶出バルーン（DEB）のタイプ別販売量（2018年-2023年） - 世界の薬剤溶出バルーン（DEB）のタイプ別売上（2018年-2023年） - 世界の薬剤溶出バルーン（DEB）のタイプ別価格 ・用途別セグメント：カテーテル検査室、病院、その他 - 世界の薬剤溶出バルーン（DEB）の用途別販売量（2018年-2023年） - 世界の薬剤溶出バルーン（DEB）の用途別売上（2018年-2023年） - 世界の薬剤溶出バルーン（DEB）の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 B. Braun、Medtronic、Boston Scientific、BD、Yinyi、Philips、Eurocor、Aachen Resonance、Biotronic ・産業チェーンと販売チャネルの分析 - 薬剤溶出バルーン（DEB）産業チェーン分析 - 薬剤溶出バルーン（DEB）の主要原材料 - 薬剤溶出バルーン（DEB）の販売チャネル - 薬剤溶出バルーン（DEB）のディストリビューター - 薬剤溶出バルーン（DEB）の主要顧客 ・薬剤溶出バルーン（DEB）市場ダイナミクス - 薬剤溶出バルーン（DEB）の業界動向 - 薬剤溶出バルーン（DEB）市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
A drug-eluting balloon is a non-stent technology in which the effective homogenous delivery of anti-proliferative drugs is processed by the vessel wall through an inflated balloon. This is done to restore luminal vascularity in order to treat atherosclerosis, in-stent restenosis and reduce the risk of late thrombosis without implanting a permanent foreign object. The balloon technology relies on the concept of targeted drug delivery, which helps in the rapid healing of the vessel wall and prevents the proliferation of smooth muscle cells.
Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure.
Highlights
The global Drug Eluting Balloons (DEB) market was valued at US$ 584 million in 2022 and is anticipated to reach US$ 1396.1 million by 2029, witnessing a CAGR of 13.1% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global Drug Eluting Balloons（DEB） key players include B. Braun, Medtronic, Boston Scientific, BD, Yinyi, etc. Global top 5 manufacturers hold a share over 84%.
Europe is the largest market, with a share about 42%, followed by North America, and Asia-Pacific, both have a share about 52 percent.
In terms of product, Peripheral DEBs is the largest segment, with a share over 57%. And in terms of application, the largest application is Hospital, followed by Catheterization Laboratory, Others.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Balloons (DEB), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Balloons (DEB).
The Drug Eluting Balloons (DEB) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drug Eluting Balloons (DEB) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Balloons (DEB) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
B. Braun
Medtronic
Boston Scientific
BD
Yinyi
Philips
Eurocor
Aachen Resonance
Biotronic
Segment by Type
Peripheral DEBs
Coronary DEBs
Segment by Application
Catheterization Laboratory
Hospital
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Eluting Balloons (DEB) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Eluting Balloons (DEB) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Drug Eluting Balloons (DEB) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Eluting Balloons (DEB) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Drug Eluting Balloons (DEB) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Drug Eluting Balloons (DEB) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Eluting Balloons (DEB).
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Eluting Balloons (DEB) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Eluting Balloons (DEB) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
1 Drug Eluting Balloons (DEB) Market Overview
1.1 Product Overview and Scope of Drug Eluting Balloons (DEB)
1.2 Drug Eluting Balloons (DEB) Segment by Type
1.2.1 Global Drug Eluting Balloons (DEB) Market Value Comparison by Type (2023-2029)
1.2.2 Peripheral DEBs
1.2.3 Coronary DEBs
1.3 Drug Eluting Balloons (DEB) Segment by Application
1.3.1 Global Drug Eluting Balloons (DEB) Market Value by Application: (2023-2029)
1.3.2 Catheterization Laboratory
1.3.3 Hospital
1.3.4 Others
1.4 Global Drug Eluting Balloons (DEB) Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Balloons (DEB) Revenue 2018-2029
1.4.2 Global Drug Eluting Balloons (DEB) Sales 2018-2029
1.4.3 Global Drug Eluting Balloons (DEB) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Drug Eluting Balloons (DEB) Market Competition by Manufacturers
2.1 Global Drug Eluting Balloons (DEB) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Drug Eluting Balloons (DEB) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Drug Eluting Balloons (DEB) Average Price by Manufacturers (2018-2023)
2.4 Global Drug Eluting Balloons (DEB) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Drug Eluting Balloons (DEB), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Eluting Balloons (DEB), Product Type & Application
2.7 Drug Eluting Balloons (DEB) Market Competitive Situation and Trends
2.7.1 Drug Eluting Balloons (DEB) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug Eluting Balloons (DEB) Players Market Share by Revenue
2.7.3 Global Drug Eluting Balloons (DEB) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug Eluting Balloons (DEB) Retrospective Market Scenario by Region
3.1 Global Drug Eluting Balloons (DEB) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Drug Eluting Balloons (DEB) Global Drug Eluting Balloons (DEB) Sales by Region: 2018-2029
3.2.1 Global Drug Eluting Balloons (DEB) Sales by Region: 2018-2023
3.2.2 Global Drug Eluting Balloons (DEB) Sales by Region: 2024-2029
3.3 Global Drug Eluting Balloons (DEB) Global Drug Eluting Balloons (DEB) Revenue by Region: 2018-2029
3.3.1 Global Drug Eluting Balloons (DEB) Revenue by Region: 2018-2023
3.3.2 Global Drug Eluting Balloons (DEB) Revenue by Region: 2024-2029
3.4 North America Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.4.1 North America Drug Eluting Balloons (DEB) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Drug Eluting Balloons (DEB) Sales by Country (2018-2029)
3.4.3 North America Drug Eluting Balloons (DEB) Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Balloons (DEB) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Drug Eluting Balloons (DEB) Sales by Country (2018-2029)
3.5.3 Europe Drug Eluting Balloons (DEB) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.6.1 Asia Pacific Drug Eluting Balloons (DEB) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Drug Eluting Balloons (DEB) Sales by Country (2018-2029)
3.6.3 Asia Pacific Drug Eluting Balloons (DEB) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Balloons (DEB) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Drug Eluting Balloons (DEB) Sales by Country (2018-2029)
3.7.3 Latin America Drug Eluting Balloons (DEB) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Balloons (DEB) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Drug Eluting Balloons (DEB) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Drug Eluting Balloons (DEB) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Eluting Balloons (DEB) Sales by Type (2018-2029)
4.1.1 Global Drug Eluting Balloons (DEB) Sales by Type (2018-2023)
4.1.2 Global Drug Eluting Balloons (DEB) Sales by Type (2024-2029)
4.1.3 Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2018-2029)
4.2 Global Drug Eluting Balloons (DEB) Revenue by Type (2018-2029)
4.2.1 Global Drug Eluting Balloons (DEB) Revenue by Type (2018-2023)
4.2.2 Global Drug Eluting Balloons (DEB) Revenue by Type (2024-2029)
4.2.3 Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2018-2029)
4.3 Global Drug Eluting Balloons (DEB) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Drug Eluting Balloons (DEB) Sales by Application (2018-2029)
5.1.1 Global Drug Eluting Balloons (DEB) Sales by Application (2018-2023)
5.1.2 Global Drug Eluting Balloons (DEB) Sales by Application (2024-2029)
5.1.3 Global Drug Eluting Balloons (DEB) Sales Market Share by Application (2018-2029)
5.2 Global Drug Eluting Balloons (DEB) Revenue by Application (2018-2029)
5.2.1 Global Drug Eluting Balloons (DEB) Revenue by Application (2018-2023)
5.2.2 Global Drug Eluting Balloons (DEB) Revenue by Application (2024-2029)
5.2.3 Global Drug Eluting Balloons (DEB) Revenue Market Share by Application (2018-2029)
5.3 Global Drug Eluting Balloons (DEB) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 B. Braun
6.1.1 B. Braun Corporation Information
6.1.2 B. Braun Description and Business Overview
6.1.3 B. Braun Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 B. Braun Drug Eluting Balloons (DEB) Product Portfolio
6.1.5 B. Braun Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Medtronic Drug Eluting Balloons (DEB) Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Corporation Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Boston Scientific Drug Eluting Balloons (DEB) Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Description and Business Overview
6.4.3 BD Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BD Drug Eluting Balloons (DEB) Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Yinyi
6.5.1 Yinyi Corporation Information
6.5.2 Yinyi Description and Business Overview
6.5.3 Yinyi Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Yinyi Drug Eluting Balloons (DEB) Product Portfolio
6.5.5 Yinyi Recent Developments/Updates
6.6 Philips
6.6.1 Philips Corporation Information
6.6.2 Philips Description and Business Overview
6.6.3 Philips Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Philips Drug Eluting Balloons (DEB) Product Portfolio
6.6.5 Philips Recent Developments/Updates
6.7 Eurocor
6.6.1 Eurocor Corporation Information
6.6.2 Eurocor Description and Business Overview
6.6.3 Eurocor Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Eurocor Drug Eluting Balloons (DEB) Product Portfolio
6.7.5 Eurocor Recent Developments/Updates
6.8 Aachen Resonance
6.8.1 Aachen Resonance Corporation Information
6.8.2 Aachen Resonance Description and Business Overview
6.8.3 Aachen Resonance Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Aachen Resonance Drug Eluting Balloons (DEB) Product Portfolio
6.8.5 Aachen Resonance Recent Developments/Updates
6.9 Biotronic
6.9.1 Biotronic Corporation Information
6.9.2 Biotronic Description and Business Overview
6.9.3 Biotronic Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Biotronic Drug Eluting Balloons (DEB) Product Portfolio
6.9.5 Biotronic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Balloons (DEB) Industry Chain Analysis
7.2 Drug Eluting Balloons (DEB) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Balloons (DEB) Production Mode & Process
7.4 Drug Eluting Balloons (DEB) Sales and Marketing
7.4.1 Drug Eluting Balloons (DEB) Sales Channels
7.4.2 Drug Eluting Balloons (DEB) Distributors
7.5 Drug Eluting Balloons (DEB) Customers
8 Drug Eluting Balloons (DEB) Market Dynamics
8.1 Drug Eluting Balloons (DEB) Industry Trends
8.2 Drug Eluting Balloons (DEB) Market Drivers
8.3 Drug Eluting Balloons (DEB) Market Challenges
8.4 Drug Eluting Balloons (DEB) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer